Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke's Medical Center
Nationally Recognized Cancer Care in Houston
The Baylor College of Medicine Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke’s Medical Center brings innovative treatments from lab to bedside faster than ever before to help stop cancer in its tracks.
Set apart from other centers by its Comprehensive Cancer Center designation by the National Cancer Institute (NCI), the Dan L Duncan Comprehensive Cancer Center (DLDCCC) provides exceptional care to patients from all over the world. As one of only three NCI-designated Comprehensive Cancer Centers in Texas, the DLDCCC is one of the best in the country and is able to contribute vital advances to cancer research through national funding. Specialized health care providers at the DLDCCC are dedicated to understanding, preventing, and treating this disease.
Making Breakthroughs in Cancer Research
Recognized for scientific and clinical excellence, the Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke’s Medical Center is home to exceptional discoveries and the development of more effective approaches to cancer prevention, diagnosis, and treatment. In addition, the center performs outstanding cancer epidemiology and prevention research and sponsors innovative clinical trials of new preventive and treatment strategies.
Baylor College of Medicine houses the largest clinical genetics program in the nation. This gives us the opportunity to analyze the genetic makeup of patients to identify the potential for cancer, take measures to prevent its onset, and develop custom treatments for each case. Our strong academic and research programs allow us to provide leading-edge cancer treatment to our patients.
We are transforming our vision of a cancer-free life into reality through the continued pursuit of focused research and the rapid translation of our new discoveries into improved patient care.